[Form 4] H.B. Fuller Company Insider Trading Activity

Rhea-AI Filing Summary

H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.

Positive

• Transparent disclosure of a sizable insider share disposition and detailed listing of outstanding equity awards and vesting schedules

Negative

• Disposition of 52,196 common shares on 08/15/2025 (sale price not disclosed in the filing)

Insights

Securities Analyst

TL;DR: Insider disposed of 52,196 shares; extensive remaining option and RSU position remains.

The disposal of 52,196 common shares on 08/15/2025 is the clearest actionable item for investors because it represents an actual reduction in direct common-share holdings by the Executive VP & CFO. The filing also enumerates numerous employee stock options (with exercise prices from $43.48 to $77.72) and restricted stock units that remain outstanding and subject to vesting schedules. Because no sale price for the disposed shares is reported on this form, valuation impact cannot be directly assessed from this filing alone. The detailed listing of derivative positions is useful for assessing potential future dilution if options are exercised or RSUs convert.

Corporate Governance Expert

TL;DR: Form 4 properly discloses a significant share disposition and enumerates remaining equity awards and vesting terms.

The filing appears to comply with Section 16 reporting by identifying the reporting person, relationship to the issuer (Executive VP & CFO), transaction date (08/15/2025), and enumerating derivative securities, phantom units, options, and restricted stock units with vesting or exercisability dates. Notably, the report lacks a transaction price for the 52,196-share disposition, which limits transparency on proceeds or economic intent. The signature by an attorney-in-fact is included with date 08/18/2025, satisfying execution disclosure requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Corkrean John J

(Last) (First) (Middle)

1200 WILLOW LAKE BOULEVARD

P.O. BOX 64683

(Street)

ST. PAUL MN 55164-0683

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								52,196	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Units	$0.0000(1)	08/15/2025		A		159.84		(2)	(2)	Common Stock	159.84	$58.97	26,199.97(3)	D
Employee Stock Option (Right-to-Buy)	$43.48							05/17/2017(4)	05/17/2026	Common Stock	16,672		16,672	D
Employee Stock Option (Right-to-Buy)	$45.05							01/24/2020(4)	01/24/2029	Common Stock	41,208		41,208	D
Employee Stock Option (Right-to-Buy)	$48.35							01/24/2021(4)	01/24/2030	Common Stock	48,309		48,309	D
Employee Stock Option (Right-to-Buy)	$50.1							01/26/2018(4)	01/26/2027	Common Stock	23,696		23,696	D
Employee Stock Option (Right-to-Buy)	$51.89							01/27/2022(4)	01/27/2031	Common Stock	38,376		38,376	D
Employee Stock Option (Right-to-Buy)	$53.57							01/25/2019(4)	01/25/2028	Common Stock	21,834		21,834	D
Employee Stock Option (Right-to-Buy)	$64.28							01/27/2026(5)	01/27/2035	Common Stock	24,570		24,570	D
Employee Stock Option (Right-to-Buy)	$68.17							01/24/2024(5)	01/24/2033	Common Stock	22,312		22,312	D
Employee Stock Option (Right-to-Buy)	$72.94							01/24/2023(4)	01/24/2032	Common Stock	21,997		21,997	D
Employee Stock Option (Right-to-Buy)	$77.72							01/26/2025(5)	01/26/2034	Common Stock	24,774		24,774	D
Restricted Stock Units	$0.0000(6)							01/24/2024(7)	01/24/2026	Common Stock	1,292.02		1,292.02(8)	D
Restricted Stock Units	$0.0000(6)							01/26/2025(7)	01/26/2027	Common Stock	2,830.02		2,830.02(8)	D
Restricted Stock Units	$0.0000(6)							01/27/2026(7)	01/27/2028	Common Stock	4,335.92		4,335.92(8)	D

Explanation of Responses:

1. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.

2. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.

3. Amount includes stock units acquired pursuant to a dividend equivalent feature.

4. This option is 100% vested.

5. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

6. These restricted stock units convert into shares of common stock on a 1-for-1 basis.

7. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

8. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.

	/s/ Patrick J. Seul, Attorney-in-Fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider is reported on the Form 4 for FUL?

The reporting person is John J. Corkrean, listed as Executive VP and CFO.

What transaction is reported and when did it occur?

A disposition of 52,196 shares of Common Stock occurred on 08/15/2025.

Does the Form 4 show the sale price for the 52,196 shares?

No. The filing lists the disposition but does not state a sale price for the 52,196-share transaction.

What types of equity awards remain outstanding for the reporting person?

The filing lists phantom units that convert 1-for-1, multiple employee stock options with exercise prices from $43.48 to $77.72 and specified share counts (for example 16,672, 41,208, 48,309), and restricted stock units (example amounts: 1,292.02, 2,830.02, 4,335.92) with stated vesting schedules.

Who signed the Form 4 and when?

The Form 4 was signed by Patrick J. Seul, Attorney-in-Fact on 08/18/2025.